Successful targeting and disruption of an integrated reporter lentivirus using the engineered homing endonuclease Y2 I-AniI.

Current antiviral therapy does not cure HIV-infected individuals because the virus establishes lifelong latent infection within long-lived memory T cells as integrated HIV proviral DNA. Here, we report a new therapeutic approach that aims to cure cells of latent HIV infection by rendering latent vir...

Full description

Bibliographic Details
Main Authors: Martine Aubert, Byoung Y Ryu, Lindsey Banks, David J Rawlings, Andrew M Scharenberg, Keith R Jerome
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-02-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3036713?pdf=render
_version_ 1811281743819309056
author Martine Aubert
Byoung Y Ryu
Lindsey Banks
David J Rawlings
Andrew M Scharenberg
Keith R Jerome
author_facet Martine Aubert
Byoung Y Ryu
Lindsey Banks
David J Rawlings
Andrew M Scharenberg
Keith R Jerome
author_sort Martine Aubert
collection DOAJ
description Current antiviral therapy does not cure HIV-infected individuals because the virus establishes lifelong latent infection within long-lived memory T cells as integrated HIV proviral DNA. Here, we report a new therapeutic approach that aims to cure cells of latent HIV infection by rendering latent virus incapable of replication and pathogenesis via targeted cellular mutagenesis of essential viral genes. This is achieved by using a homing endonuclease to introduce DNA double-stranded breaks (dsb) within the integrated proviral DNA, which is followed by triggering of the cellular DNA damage response and error-prone repair. To evaluate this concept, we developed an in vitro culture model of viral latency, consisting of an integrated lentiviral vector with an easily evaluated reporter system to detect targeted mutagenesis events. Using this system, we demonstrate that homing endonucleases can efficiently and selectively target an integrated reporter lentivirus within the cellular genome, leading to mutation in the proviral DNA and loss of reporter gene expression. This new technology offers the possibility of selectively disabling integrated HIV provirus within latently infected cells.
first_indexed 2024-04-13T01:39:06Z
format Article
id doaj.art-d116fef6093248cf93b87e56d25ff3c4
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T01:39:06Z
publishDate 2011-02-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-d116fef6093248cf93b87e56d25ff3c42022-12-22T03:08:16ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-02-0162e1682510.1371/journal.pone.0016825Successful targeting and disruption of an integrated reporter lentivirus using the engineered homing endonuclease Y2 I-AniI.Martine AubertByoung Y RyuLindsey BanksDavid J RawlingsAndrew M ScharenbergKeith R JeromeCurrent antiviral therapy does not cure HIV-infected individuals because the virus establishes lifelong latent infection within long-lived memory T cells as integrated HIV proviral DNA. Here, we report a new therapeutic approach that aims to cure cells of latent HIV infection by rendering latent virus incapable of replication and pathogenesis via targeted cellular mutagenesis of essential viral genes. This is achieved by using a homing endonuclease to introduce DNA double-stranded breaks (dsb) within the integrated proviral DNA, which is followed by triggering of the cellular DNA damage response and error-prone repair. To evaluate this concept, we developed an in vitro culture model of viral latency, consisting of an integrated lentiviral vector with an easily evaluated reporter system to detect targeted mutagenesis events. Using this system, we demonstrate that homing endonucleases can efficiently and selectively target an integrated reporter lentivirus within the cellular genome, leading to mutation in the proviral DNA and loss of reporter gene expression. This new technology offers the possibility of selectively disabling integrated HIV provirus within latently infected cells.http://europepmc.org/articles/PMC3036713?pdf=render
spellingShingle Martine Aubert
Byoung Y Ryu
Lindsey Banks
David J Rawlings
Andrew M Scharenberg
Keith R Jerome
Successful targeting and disruption of an integrated reporter lentivirus using the engineered homing endonuclease Y2 I-AniI.
PLoS ONE
title Successful targeting and disruption of an integrated reporter lentivirus using the engineered homing endonuclease Y2 I-AniI.
title_full Successful targeting and disruption of an integrated reporter lentivirus using the engineered homing endonuclease Y2 I-AniI.
title_fullStr Successful targeting and disruption of an integrated reporter lentivirus using the engineered homing endonuclease Y2 I-AniI.
title_full_unstemmed Successful targeting and disruption of an integrated reporter lentivirus using the engineered homing endonuclease Y2 I-AniI.
title_short Successful targeting and disruption of an integrated reporter lentivirus using the engineered homing endonuclease Y2 I-AniI.
title_sort successful targeting and disruption of an integrated reporter lentivirus using the engineered homing endonuclease y2 i anii
url http://europepmc.org/articles/PMC3036713?pdf=render
work_keys_str_mv AT martineaubert successfultargetinganddisruptionofanintegratedreporterlentivirususingtheengineeredhomingendonucleasey2ianii
AT byoungyryu successfultargetinganddisruptionofanintegratedreporterlentivirususingtheengineeredhomingendonucleasey2ianii
AT lindseybanks successfultargetinganddisruptionofanintegratedreporterlentivirususingtheengineeredhomingendonucleasey2ianii
AT davidjrawlings successfultargetinganddisruptionofanintegratedreporterlentivirususingtheengineeredhomingendonucleasey2ianii
AT andrewmscharenberg successfultargetinganddisruptionofanintegratedreporterlentivirususingtheengineeredhomingendonucleasey2ianii
AT keithrjerome successfultargetinganddisruptionofanintegratedreporterlentivirususingtheengineeredhomingendonucleasey2ianii